Exclusivity of products, brought about through patenting or exclusive licencing, can affect pharmaceutical prices and affordability, especially in developing countries [7].
According to market analysts, pharmaceuticals have increasingly narrow profit margins, especially in developing world contexts where generics are providing greater competition (e.g. Frost & Sullivan, 2011).
Pharmaceuticals are an integral component of health care systems worldwide, thus, regulatory weaknesses in governance of the pharmaceutical system negatively impact health outcomes especially in developing countries [ 1].
Women's earning potential remains compromised, especially in developing countries.
This could be especially important in developing countries with nascent pharmaceutical industries, who may synthesize and sell their own diclofenac formulations.
That is especially true in developing countries.
This has proved especially valuable in developing Sino-German trade.
This has been especially apparent in developing countries like Mexico.
Its administration requires no electricity, oxygen, or even trained anesthetists, making it a particularly useful pharmaceutical in developing nations.
Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs.
